Abstract
The alarming spread of the pandemic coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is requiring several measures to reduce the risk of contagion. Every successful strategy in controlling SARS-CoV2 infection depends on the timely viral diagnosis which should include asymptomatic carriers. Consequently, strategies to increase the throughput for clinical laboratories to conduct large-scale diagnostic testing are urgently needed. Here we support the hypothesis that standard diagnostic protocol for SARS-CoV-2 virus could be conveniently applied to pooled samples obtained from different subjects. We suggest that a two-step sequential pooling procedure could identify positive subjects, ensuring at the same time significant benefits of costs and time. Simulation data are used to assess the efficiency, in terms of number of required tests, both for random assignment of the subjects to the pools and for situations when epidemiological and clinical data are used to create an “informed” version of the pooling. Different scenarios are examined in the simulations to measure the effect of different pool sizes and different values for the virus frequency. Our results allow to customize the pooling strategy according to the specific characteristics of the cohort to be tested.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
author: cinzia.mortarino{at}unipd.it
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are fully available without restriction.All relevant data are within the manuscript and its Supporting Information files. The corresponding author is cinzia.mortarino{at}unipd.it
